Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events latest research released supporting new understanding how aorta functions
… a world leader in in-vitro diagnostics, conducted research to determine the clinical and economic impact of … tests GFAP+UCH-L1 or S100B all in one analysis. The research contributes to growing evidence that the biomarker …
… a reality. The first 10 drugs have been selected for the new Medicare Drug Price Negotiation Program and have begun … (HTAR) is due to be introduced in January 2025 for new oncology medicines, advanced therapies (also known as … in January 2028. And finally, regulation for all new medicines will start in January 2030. This has left some …
… a Marketing Specialist with RTI-HS. Ms. Howze’s focus is events, project managements, and content creation. She has a … su ch as The Washington Post , The Huffington Post , U.S. News & World Report , and MTV News. …
… Using Real-World Data A Challenge of Real World Data: How to Assign Individuals to a Treatment Strategy When Their … a decade in fields like HIV, cardiovascular, and cancer research. In this study we explored an alternative to … and wider confidence intervals. Read more about the research at this link . …
… audience, provides an overview of interdisciplinary research partnerships that leverage artificial intelligence, industrial engineering, and operations research to tackle societal and operational problems in … outline that many variables factor into the decision of how, if at all, a screening test should be used, including …
… April 15 - Thursday, April 18, 2024 Conference website Research coauthored by RTI Health Solutions will be presented … you are attending, please stop by our posters and see our research on Avelumab therapy and Fetal and neonatal …
Are Real-World Testing Patterns for RET Gene Mutation with Medullary Thyroid Cancer Consistent with National Guidelines? Share on: April 10, 2023 Medullary thyroid cancer (MTC) is a rare cancer, generally diagnosed at early stages of the disease when …
… for natalizumab compared with fingolimod. In addition to supporting the cost-effectiveness of natalizumab as a … disease-modifying therapy for relapsing-remitting MS, this research represents an important step forward as the first … data in an economic evaluation for MS. Learn more about how RTI Health Solutions can assist you in analyzing and …
… clinical and commercial teams alike, we provide extensive research experience, industry and regulatory knowledge, and …
… and technology assessment submission needs: Utility research design (trials, observational studies, surveys) … instruments will be considered. • Methods for conducting research and identifying information on QOL must be described … for Economic Evaluations in Healthcare (ZiN, 2024) New Zealand PHARMAC EQ-5D (recommended or preferred MAUI). …